NCT05734391
Surveillance of Healthcare-associated Infections & Antimicrobial Resistance
Enrolling by Invitation
Not specifiedAll AgesObservationalUniversity of PennsylvaniaInvestigator-initiated
~1,500 participants
Updated 2025-09-12 on ClinicalTrials.gov
What's tested:Routine Infection control
At a glance
Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Expertise
Measured over 12 months
Conditions
Where it's being run
2 sites across 2 statesPennsylvania1
Botswana1
Study leadership
- Ebbing Lautenbach, MD, MPH, MSCE · PRINCIPAL_INVESTIGATOR · University of Pennsylvania
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
hospital inpatient admission to participating wards.
Exclusion
diagnosis of a bleeding disorder
platelet counts of \<50,000
diagnosis of coagulopathy
presence of active bleeding
inability to have a nares swab collected due to some other condition where nasal swabbing would be contraindicated
inability to have a rectal swab collected due to some other condition where rectal swabbing would be contraindicated
What this trial measures
- Expertise12 months
Ultimately, the goal of the SHARE project is to assemble the expertise and infrastructure needed to build a resilient HAI/AMR surveillance system fully-incorporated into MOHW's surveillance activities. The project aims to build capacity, both material and knowledge, in existing laboratory and IPC teams to face the dynamic challenges posed by HAIs and AMR